First Human Trial of Reverse-Aging Cellular Reprogramming Treatment Begins
Boston-based biotech startup Life Biosciences has injected a cellular reprogramming treatment into a human patient for the first time, marking a milestone in longevity science. The technique, based on Yamanaka Factors discovered in 2007, aims to reprogram aging cells to act younger while maintaining their function. The trial represents a significant step toward testing whether epigenetic reprogramming can reverse age-related diseases in humans, with major investors including Jeff Bezos, Sam Altman, Eli Lilly, and Merck backing similar efforts.
Life Biosciences announced that its first patient has received an injection of ER-100, a cellular reprogramming treatment designed to reverse age-related diseases. The injection was administered to the patient's eye to treat glaucoma. The trial builds on decades of research into cellular reprogramming, a technique based on the Yamanaka Factors—four proteins discovered by Nobel laureate Shinya Yamanaka that can reprogram adult cells to behave like younger cells. Rather than fully reverting cells to an undifferentiated state, the goal is partial reprogramming to make cells more youthful and resilient while preserving their function. The initial FDA trial will involve fewer than 20 patients, with researchers monitoring safety and efficacy over six months. The breakthrough has attracted significant investment from billionaires and pharmaceutical companies, including Eli Lilly, Merck, Jeff Bezos, and Sam Altman, who are funding competing approaches through companies like Altos Labs and Retro Biosciences.
Limitations & open questions
The article does not provide details about the patient's age, baseline health status, or specific glaucoma severity, which would be relevant for assessing the treatment's potential impact. Additionally, no information is given about the specific mechanisms by which ER-100 delivers or activates the Yamanaka Factors, or the rationale for choosing glaucoma as the initial indication for testing.
What different sources said
- ScienceAlertCenter
World First: Patient Receives High-Risk Therapy to Make Cells Young Again
- Business InsiderLeft
The first-ever reverse-aging drug was just injected into a human
- Science DailyCenter
Scientists discover a hidden cause of aging cells that can be reversed
- Medical XpressCenter
Novel gene therapy platform restores muscle function in Duchenne muscular dystrophy model
- Mirage NewsCenter
Gene Therapy Restores Muscle in Duchenne Models
- Nature NewsCenter
World-first: therapy to make cells young again given to a person
- EuronewsCenter
Is it possible to rejuvenate damaged human cells? US biotech firm tests new gene therapy
- MIT Technology ReviewCenter
Why “reprogramming” is the buzziest approach to reversing aging right now
Related
Nobel Laureates Rebut Study Claiming Universe's Expansion Is Slowing, Confirm Acceleration Continues
An international team of astrophysicists, including Nobel laureates Adam Riess and Brian Schmidt, has published a study in the Monthly Notices of the Royal Astronomical Society confirming that the universe's expansion is still accelerating. The rebuttal targets a late-2024 South Korean study that had claimed dark energy was weakening, a finding that would have overturned nearly three decades of cosmological understanding. The new study identifies two specific methodological errors in the earlier work, restoring confidence in the standard model of cosmic acceleration while leaving the deeper mystery of what dark energy actually is unresolved.
Study Finds Trees May Store Less Carbon Than Climate Models Predict
A new study published in Science Advances found that oak trees stop growing months before they stop photosynthesizing, meaning increased carbon uptake does not necessarily translate into more wood growth and long-term carbon storage. Researchers analyzed 137 sites across the US, finding that 26–36% of annual carbon uptake occurred after tree growth had already ceased, with drought and heat identified as key triggers for halting growth. The findings suggest that widely used climate models, which assume photosynthesis and growth are tightly linked, may be overestimating forests' future capacity to sequester carbon.
San Andreas Fault Stress Reaches Highest Level in 1,000 Years, Study Finds
A new peer-reviewed study finds that tectonic stress on Southern California's San Andreas and San Jacinto fault systems has reached its highest levels in at least 1,000 years, with the San Jacinto-Bernardino section measuring 3.6 megapascals. The research, led by the University of Hawaiʻi at Mānoa and published in the Journal of Geophysical Research: Solid Earth, used a computer model drawing on geological data including radiocarbon dating and tree-ring records to reconstruct a millennium of earthquake history. The findings cannot predict when a major earthquake will occur but are intended to improve hazard assessments, inform building codes, and guide emergency preparedness in a region home to millions.